According to the data, participants with advanced or metastatic UC who had received extensive pretreatment showed encouraging anticancer activity with a tolerable safety...
The U.S. Food and Drug Administration (FDA) has approved the first generic version of Victoza (liraglutide injection), a glucagon-like peptide-1 (GLP-1) receptor...